State Street’s TriSalus Life Sciences TLSI Stock Holding History

State Street’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.78M	Buy	610,963 +282,943	+86%	+$1.12M	﹤0.01%	3224
2026 Q1	$1.31M	Buy	328,020 +63,392	+24%	+$310K	﹤0.01%	3425
2025 Q4	$1.85M	Buy	264,628 +71,995	+37%	+$403K	﹤0.01%	3365
2025 Q3	$896K	Buy	192,633 +77,036	+67%	+$361K	﹤0.01%	3537
2025 Q2	$630K	Buy	115,597 +95,397	+472%	+$512K	﹤0.01%	3574
2025 Q1	$112K	Hold	20,200	–	–	﹤0.01%	3951
2024 Q4	$101K	Buy	20,200 +9,100	+82%	+$38.5K	﹤0.01%	3985
2024 Q3	$51.2K	Hold	11,100	–	–	﹤0.01%	4094
2024 Q2	$61.3K	Buy	+11,100	New	+$94.1K	﹤0.01%	4111
2022 Q1	–	Sell	-11,409	Closed	-$113K	–	4926
2021 Q4	$113K	Buy	+11,409	New	+$113K	﹤0.01%	4552

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

State Street's TLSI Position: Q2 2026 in Review

State Street increased its TriSalus Life Sciences (TLSI) stake by 86% in Q2 2026, buying an estimated $1.12M and bringing the position to 610,963 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3224.

State Street first reported a position in TLSI in Q4 2021 and has held it in 10 quarters since. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

State Street held 610,963 shares of TriSalus Life Sciences worth $2.78M as of Q2 2026.
State Street bought 282,943 TriSalus Life Sciences shares in Q2 2026, an estimated $1.12M.
TriSalus Life Sciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3224 holding.
State Street first reported a position in TriSalus Life Sciences in Q4 2021 and has held it in 10 quarters since.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.